Below are the most recent publications written about "Tissue Plasminogen Activator" by people in Profiles.
-
Elawady SS, Abo Kasem R, Mulpur B, Cunningham C, Matsukawa H, Sowlat MM, Orscelik A, Nawabi NLA, Isidor J, Maier I, Jabbour P, Kim JT, Wolfe SQ, Rai A, Starke RM, Psychogios MN, Samaniego EA, Yoshimura S, Cuellar H, Howard BM, Alawieh A, Alaraj A, Ezzeldin M, Romano DG, Tanweer O, Mascitelli JR, Fragata I, Polifka AJ, Siddiqui F, Osbun JW, Grandhi R, Crosa RJ, Matouk C, Park MS, Brinjikji W, Moss M, Daglioglu E, Williamson R, Navia P, Kan P, De Leacy RA, Chowdhry SA, Altschul D, Spiotta AM, Levitt MR, Goyal N. Comparison of combined intravenous and intra-arterial thrombolysis with intravenous thrombolysis alone in stroke patients undergoing mechanical thrombectomy: a propensity-matched analysis. J Neurointerv Surg. 2025 Jun 01; 17(e2):e261-e268.
-
Safran JP, Momenaei B, Martin J, Crain B, Richards C, Kaiser R, Garg SJ, Sivalingam A, Spirn M, Hsu J. RHEGMATOGENOUS RETINAL DETACHMENT AFTER VITRECTOMY AND SUBRETINAL TISSUE PLASMINOGEN ACTIVATOR FOR SUBMACULAR HEMORRHAGE. Retina. 2025 06 01; 45(6):1043-1049.
-
G?nkan A, Ferreira MY, Vilardo M, Scarcia L, Bocanegra-Becerra JE, Cardoso LJC, Fabrini Paleare LF, de Oliveira Almeida G, Semione G, Ferreira C, Ciccio G, Mujanovic A, Jabbour P, Serulle Y, Nguyen TN, Baron JC. Thrombolysis for Ischemic Stroke Beyond the 4.5-Hour Window: A Meta-Analysis of Randomized Clinical Trials. Stroke. 2025 Mar; 56(3):580-590.
-
Ash M, Dimisko L, Chalhoub RM, Howard BM, Cawley CM, Matouk C, Pabaney A, Spiotta AM, Jabbour P, Maier I, Wolfe SQ, Rai AT, Kim JT, Psychogios MN, Mascitelli JR, Starke RM, Shaban A, Yoshimura S, De Leacy R, Kan P, Fragata I, Polifka AJ, Arthur AS, Park MS, Crosa RJ, Williamson R, Dumont TM, Levitt MR, Al Kasab S, Tjoumakaris SI, Liman J, Saad H, Samaniego EA, Fargen KM, Grossberg JA, Alawieh A. Comprehensive analysis of the impact of procedure time and the 'golden hour' in subpopulations of stroke thrombectomy patients. J Neurointerv Surg. 2024 Oct 14; 16(11):1069-1075.
-
Yedavalli V, Salim H, Musmar B, Adeeb N, El Naamani K, Henninger N, Sundararajan SH, K?hn AL, Khalife J, Ghozy S, Scarcia L, Tan BY, Heit JJ, Regenhardt RW, Cancelliere NM, Bernstock JD, Rouchaud A, Fiehler J, Sheth S, Essibayi MA, Puri AS, Dyzmann C, Colasurdo M, Barreau X, Renieri L, Filipe JP, Harker P, Radu RA, Marotta TR, Spears J, Ota T, Mowla A, Jabbour P, Biswas A, Claren?on F, Siegler JE, Nguyen TN, Varela R, Baker A, Altschul D, Gonzalez NR, M?hlenbruch MA, Costalat V, Gory B, Paul Stracke C, Aziz-Sultan MA, Hecker C, Shaikh H, Liebeskind DS, Pedicelli A, Alexandre AM, Tancredi I, Faizy TD, Kalsoum E, Lubicz B, Patel AB, Pereira VM, Guenego A, Dmytriw AA. Pretreatment predictors of very poor clinical outcomes in medium vessel occlusion stroke patients treated with mechanical thrombectomy. Int J Stroke. 2024 12; 19(10):1123-1133.
-
Jiang Y, Ji Y, Zhou IY, Liu N, Sun PZ, Ning M, Dumont AS, Wang X. Effects of the New Thrombolytic Compound LT3001 on Acute Brain Tissue Damage After Focal Embolic Stroke in Rats. Transl Stroke Res. 2024 02; 15(1):30-40.
-
Isaac E, Saherwal AA, Alam S. Systemic thrombolysis for acute central retinal artery occlusion in sickle cell disease: Case report. J Natl Med Assoc. 2022 Dec; 114(6):589-592.
-
Eskin B. In ischemic stroke, IV alteplase within 3 h of onset improves functional outcome vs. control. Ann Intern Med. 2022 09; 175(9):JC107.
-
Al Saiegh F, Velagapudi L, Khanna O, Baldassari MP, Mouchtouris N, Hafazalla K, Roussis J, DePrince M, Tjoumakaris S, Gooch MR, Herial N, Rosenwasser RH, Jabbour P. Improved Functional Outcomes of Stroke Patients Undergoing Mechanical Thrombectomy After Arriving via a Mobile Stroke Unit. World Neurosurg. 2022 10; 166:e546-e550.
-
Eskin B. In acute ischemic stroke, EVT alone vs. IV alteplase plus EVT did not differ for functional outcome at 90 d. Ann Intern Med. 2022 04; 175(4):JC42.